Article Figures & Data
Figures
- Figure 1.
PASI-75, PASI-50, and sPGA Responses at Week 16
Data are the full analysis set, last observation carried forward (N = 411). PASI, Psoriasis Area and Severity Index; sPGA, Static Physician's Global Assessment.
*P < .0001 vs placebo; sPGA score of 0 (clear) or 1 (almost clear) with ≥2-point reduction from baseline.
Reproduced with permission from C Paul, MD.
- Figure 2.
PASI-50, PASI-75, and PASI-90 Throughout 32 Weeks in Patients Receiving Apremilast From Baselinea
PASI, Psoriasis Area and Severity Index.
aData using nonresponder imputation at each time point.
Reproduced with permission from C Paul, MD.
Tools
ESTEEM 2: Apremilast Significantly Reduced Psoriasis Severity Throughout 16 Weeks
Permalink:
Table of contents
Cited By...
- No citing articles found.